Literature DB >> 24711273

Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry.

Michael E Lassman1, Theresa M McLaughlin, Haihong Zhou, Yi Pan, Santica M Marcovina, Omar Laterza, Thomas P Roddy.   

Abstract

RATIONALE: Apolipoprotein(a) is a polymorphic glycoprotein covalently bound to apoB100 in Lp(a) particles and has been described to be both atherogenic and prothrombotic, although its exact mechanism of action is not well defined. Apolipoprotein(a) is routinely measured by immunoassays. Unfortunately, the accuracy of the measurement can be affected by the apolipoprotein(a) size (number of kringles) polymorphism in Lp(a) particles. Here we describe an ultra-performance liquid chromatography/mass spectrometry (UPLC/MS) assay that is capable of measuring apolipoprotein(a) concentrations while simultaneously determining the number of kringles present per protein.
METHODS: Plasma samples were diluted and proteins de-lipidated with deoxycholate prior to tryptic digestion. Distinct tryptic peptides from different regions of apolipoprotein(a) were measured to determine both concentration and the number of kringles present per protein. Separation and quantitation of tryptic peptides is carried out at 700 μL/min using a 1.7 µm C18 column (2.1 × 100 mm) coupled to a Thermo Vantage triple quadrupole (QQQ) mass spectrometer with a heated electrospray ionization (HESI) source.
RESULTS: This method was compared to established methods for measuring concentration (monoclonal antibody based ELISA) and size (gel-electrophoresis) using 80 plasma samples proved by NWLRL. The slope and r(2) value for the correlation of concentrations were determined to be 0.96 and 0.98, demonstrating excellent agreement of absolute values between the UPLC/MS and ELISA methods. As measured by UPLC/MS, the average kringle number or size is smaller than determined by the electrophoretic method.
CONCLUSIONS: A single UPLC/MS method was developed capable of measuring apolipoprotein(a) concentration and size (by measuring the number of kringles per protein). This assay passes criteria required for 'fit for purpose' assays including sensitivity, intra and interday reproducibility and freeze/thaw stability. While the agreement between UPLC/MS and ELISA is excellent for concentration and may provide researchers with additional tools for studying apolipoprotein(a), the dissimilarities between UPLC/MS and the electrophoretic method may also be exploited for understanding apolipoprotein(a) structure and function.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24711273     DOI: 10.1002/rcm.6883

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  10 in total

Review 1.  Lipoprotein (a) measurements for clinical application.

Authors:  Santica M Marcovina; John J Albers
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

2.  A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Authors:  Valentin Blanchard; Damien Garçon; Catherine Jaunet; Kevin Chemello; Stéphanie Billon-Crossouard; Audrey Aguesse; Aya Garfa; Gilles Famchon; Amada Torres; Cédric Le May; Matthieu Pichelin; Edith Bigot-Corbel; Gilles Lambert; Bertrand Cariou; Samy Hadjadj; Michel Krempf; Kalyane Bach-Ngohou; Mikaël Croyal
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

3.  Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MS.

Authors:  Mikaël Croyal; Fanta Fall; Véronique Ferchaud-Roucher; Maud Chétiveaux; Yassine Zaïr; Khadija Ouguerram; Michel Krempf; Estelle Nobécourt
Journal:  J Lipid Res       Date:  2016-01-15       Impact factor: 5.922

4.  Lipoprotein(a) Elevation: A New Diagnostic Code with Relevance to Service Members and Veterans.

Authors:  Renata J M Engler; Emily Brede; Todd Villines; Marina N Vernalis
Journal:  Fed Pract       Date:  2019-11

5.  Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a).

Authors:  Santica M Marcovina; Noémie Clouet-Foraison; Marlys L Koschinsky; Mark S Lowenthal; Allen Orquillas; Michael B Boffa; Andrew N Hoofnagle; Tomáš Vaisar
Journal:  Clin Chem       Date:  2021-03-01       Impact factor: 12.167

6.  Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.

Authors:  Gerd Schmitz; Evelyn Orsó
Journal:  Clin Res Cardiol Suppl       Date:  2015-04

7.  Serum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers.

Authors:  Qingqing Wang; Suhong Zhang; Lili Guo; Christine M Busch; Wenying Jian; Naidong Weng; Nathaniel W Snyder; Kannan Rangiah; Clementina Mesaros; Ian A Blair
Journal:  Bioanalysis       Date:  2015-09-22       Impact factor: 2.681

8.  Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies.

Authors:  Evelyn Orsó; Gerd Schmitz
Journal:  Clin Res Cardiol Suppl       Date:  2017-03

Review 9.  Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?

Authors:  Natalie C Ward; Karam M Kostner; David R Sullivan; Paul Nestel; Gerald F Watts
Journal:  J Clin Med       Date:  2019-11-27       Impact factor: 4.241

Review 10.  Lp(a): When and how to measure it.

Authors:  Jaimini Cegla; Michael France; Santica M Marcovina; R Dermot G Neely
Journal:  Ann Clin Biochem       Date:  2020-10-28       Impact factor: 2.057

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.